OTC · Financial Statements

Cryomass Technologies Inc. (CRYM) Financial Statements

$0.00 OTC: CRYM Market Cap $47432

Cryomass Technologies Inc. most recently reported annual revenue of $0, net profit of $-13.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$1.0M$0$0$0
Operating Profit$-3.0M$-7.0M$-8.0M$-10.0M$-11.0M
Net Profit$-3.0M$-12.0M$-10.0M$-10.0M$-13.0M
EPS$-0.03$-0.12$-0.06$-0.05$-0.06
Op Margin-18265.0%-836.3%——-79560.2%

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$16.0M$8.0M$16.0M$8.0M$1.0M
Total Liabilities$2.0M$4.0M$2.0M$3.0M$7.0M
Cash$3.0M$0$6.0M$2.0M$0
Borrowings$2.0M$0$0$2.0M$4.0M

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-2.0M$-4.0M$-6.0M$-5.0M$-4.0M
Investing Cash Flow$-2.0M$-1.0M$-3.0M$-1.0M$0
Financing Cash Flow$0$0$-1.0M$0$0
Net Cash Flow$3.0M$-3.0M$5.0M$-4.0M$-2.0M
Free Cash Flow$-2.0M$-4.0M$-6.0M$-5.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.37
FCF Yield-8178.48%
Quick Ratio0.06
Interest Coverage-27.72
Return 1Y-60.00%
Return 3Y-99.85%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
CRYM Overview CRYM Dividend Run Stock Screener